Markets

Market Nav

News Details

28/07/2017 11:50

Dr. Reddy's Lab extends fall post Q1; scrip down 6%

Shares of Dr. Reddy's Laboratories continued on a losing streak on Friday and tumbled nearly 6 per cent on the Bombay stock Exchange after the drug maker’s net profit declined more than half to Rs 59 crore in Q1FY18 from Rs 126 crore in the same quarter year ago.

Extending previous session losses, shares of the company declined as much as 5.98 per cent to hit intra-day low of Rs 2465.00 apiece on the Bombay Stock Exchange. The stocks were currently trading at Rs 2481.50 against previous close price of Rs 2621.45.

In a similar fashion, shares of the pharma company were trading 5.42 per cent lower at Rs 2,478.45 apiece on the National Stock Exchange.

Meanwhile, the broader benchmark BSE Sensex was trading at 32,221.62, down 161.68 points, or 0.50 per cent, at 11:44 hours.